Splicing modulator FR901464 is a potential agent for colorectal cancer in combination therapy

FR901464 (FR) was first described as an anticancer drug and later identified as a modulator of splicing factor 3B subunit 1 (SF3B1). Although the effectiveness of splicing modulators has been investigated in colorectal cancer (CRC) cells, their usefulness in animal experiments has not been confirmed...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Yamano, Tomoki, Kubo, Shuji, Yano, Aya, Kominato, Tomoko, Tanaka, Shino, Ikeda, Masataka, Tomita, Naohiro
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2019
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6349454/
https://ncbi.nlm.nih.gov/pubmed/30719229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26564
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы